LifeMD Stock Forecast
NASDAQ: LFMDHealth CareMedical/Nursing ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LFMD analyst consensus
Consensus (8 analysts)
none
Avg. price target
$8.13+191.40%
- Strong buy 0
- Buy 8
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 8 Wall Street analysts covering LifeMD (2026-10-08), 8 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $8.13, with a high estimate of $15.00 and a low estimate of $5.00. The average target implies upside of 191.4% from the current price of $2.79.
The spread between the highest and lowest targets is 200.0%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LFMD.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 8 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $5.00 | +79.21% |
| Average target | $8.13 | +191.40% |
| High target | $15.00 | +437.63% |